Growth Metrics

Innoviva (INVA) Cash from Investing Activities (QoQ) (2010 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -49.10%
Jun 30, 2025 195.52%
Sep 30, 2022 -1,801.51%
Jun 30, 2022 98.24%
Sep 30, 2021 -29.32%
Jun 30, 2021 441.07%
Mar 31, 2021 91.63%
Dec 31, 2020 -3,611.54%
Sep 30, 2020 -21.43%
Jun 30, 2020 -143.63%
Mar 31, 2020 -69.14%
Dec 31, 2019 426.25%
Sep 30, 2019 -179.26%
Jun 30, 2019 127.11%
Mar 31, 2019 -62.67%
Dec 31, 2018 -437.18%
Sep 30, 2018 48.95%
Jun 30, 2018 -65.76%
Mar 31, 2018 202.45%
Dec 31, 2017 -18.86%
Sep 30, 2017 -1,176.32%
Jun 30, 2017 -90.97%
Mar 31, 2017 -3.97%
Dec 31, 2016 254.49%
Sep 30, 2016 38.38%
Jun 30, 2016 -309.51%
Mar 31, 2016 -88.22%
Dec 31, 2015 307.39%
Sep 30, 2015 -240.62%
Jun 30, 2015 -53.81%
Mar 31, 2015 976.35%
Dec 31, 2014 85.87%
Sep 30, 2014 -430.04%
Jun 30, 2014 -179.50%
Mar 31, 2014 1,090.88%
Dec 31, 2013 98.57%
Sep 30, 2013 -35.46%
Jun 30, 2013 -63.36%
Mar 31, 2013 -30,930.14%
Dec 31, 2012 100.43%
Sep 30, 2012 -1.85%
Jun 30, 2012 -494.81%
Mar 31, 2012 84.39%
Dec 31, 2011 145.94%
Sep 30, 2011 79.90%
Jun 30, 2011 -3,873.37%
Mar 31, 2011 93.13%
Dec 31, 2010 -261.18%